Summary
This prediction ended on 08.03.17 with a price of €7.91. The BUY prediction by elbawind finished with a performance of 11.54%. elbawind has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -33.184% | -33.184% | -41.789% | -72.004% |
iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
Comments by elbawind for this prediction
In the thread Evotec AG diskutieren
nun steig ich wieder ein
am 12.1. war ich ausgestiegen, das war gut so! Inzwischen ist der Kurs gute 10% gesunken und da er gerade eine Unterstützung bildet, steige ich wieder ein. Die Tendenz des OBV ist zwar noch nicht optimal, ich rechne aber kurzfristig mit einer Wende.